Microbiology: Gut reaction

被引:33
作者
Abbott, A
机构
[1] Nature's senior European correspondent,
关键词
D O I
10.1038/427284a
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Consumers are stocking up on live yoghurts and fermented drinks that claim to improve health. But is there any science behind the marketing of these 'probiotic' products? Alison Abbott investigates.
引用
收藏
页码:284 / 286
页数:3
相关论文
共 11 条
[1]   Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea [J].
Cremonini, F ;
Di Caro, S ;
Nista, EC ;
Bartolozzi, F ;
Capelli, G ;
Gasbarrini, G ;
Gasbarrini, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (08) :1461-1467
[2]   Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis [J].
D'Souza, AL ;
Rajkumar, C ;
Cooke, J ;
Bulpitt, CJ .
BRITISH MEDICAL JOURNAL, 2002, 324 (7350) :1361-1364
[3]   Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Brigidi, P ;
Matteuzzi, D ;
Bazzocchi, G ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2000, 119 (02) :305-309
[4]   Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea:: A multicenter European trial [J].
Guandalini, S ;
Pensabene, L ;
Abu Zikri, M ;
Dias, JA ;
Casali, LG ;
Hoekstra, H ;
Kolacek, S ;
Massar, K ;
Micetic-Turk, D ;
Papadopoulou, A ;
de Sousa, JS ;
Sandhu, B ;
Szajewska, H ;
Weizman, Z .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 30 (01) :54-60
[5]   Probiotics and prevention of atopic disease:: 4-year follow-up of a randomised placebo-controlled trial [J].
Kalliomäki, M ;
Salminen, S ;
Poussa, T ;
Arvilommi, H ;
Isolauri, E .
LANCET, 2003, 361 (9372) :1869-1871
[6]   Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial [J].
Kalliomäki, M ;
Salminen, S ;
Arvilommi, H ;
Kero, P ;
Koskinen, P ;
Isolauri, E .
LANCET, 2001, 357 (9262) :1076-1079
[7]   Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:: a randomised trial [J].
Rembacken, BJ ;
Snelling, AM ;
Hawkey, PM ;
Chalmers, DM ;
Axon, ATR .
LANCET, 1999, 354 (9179) :635-639
[8]   Lactobacilli as live vaccine delivery vectors: progress and prospects [J].
Seegers, JFML .
TRENDS IN BIOTECHNOLOGY, 2002, 20 (12) :508-515
[9]   Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 [J].
Steidler, L ;
Neirynck, S ;
Huyghebaert, N ;
Snoeck, V ;
Vermeire, A ;
Goddeeris, B ;
Cox, E ;
Remon, JP ;
Remaut, E .
NATURE BIOTECHNOLOGY, 2003, 21 (07) :785-789
[10]   Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 [J].
Steidler, L ;
Hans, W ;
Schotte, L ;
Neirynck, S ;
Obermeier, F ;
Falk, W ;
Fiers, W ;
Remaut, E .
SCIENCE, 2000, 289 (5483) :1352-1355